Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y112

Event date: 2023-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-23-000974
Form type
SC 13G/A
Filer
LENSAR, Inc.
CIK
CIK 1320350
Filed
Dec 11, 2023
Reporting period
Nov 30, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub